Hao-Fountain Syndrome

On this page
  1. Description
  2. Signs and Symptoms
  3. Causes
  4. Laboratory Investigations
  5. Treatment and Therapies
  6. Outlook
  7. Related Disorders
  8. Resources
  9. Research
  10. Family Stories
  11. References

Summary

Hao-Fountain syndrome is a rare genetic neurodevelopmental disorder caused by changes in the USP7 gene. This syndrome leads to developmental delay/intellectual disability, severe speech delay, autism spectrum disorder, increased prevalence of epilepsy, abnormal brain MRIs, and motor impairments. Additional clinical features include an increased prevalence of neonatal hypotonia, feeding problems, joint contractures, hypogonadism and eye problems. The severity and specific symptoms can vary widely. While there is no cure, early intervention and supportive therapies can improve quality of life for those affected and their families.

Description

Hao-Fountain Syndrome (HAFOUS, for short), also known as USP7-related disorder, is a neurodevelopmental disorder caused by a disruption in the USP7 gene. The USP7 gene, located on the short (p) arm of chromosome 16 (16p13.2), encodes for the USP7 protein, which plays a role in tumor suppression, transcriptional regulation (control over the process of converting DNA into a protein), immune response, and endosomal protein recycling1-4.

There are no formal subtypes, but symptoms can range from mild to severe. Most cases are not inherited and happen as new (de novo) mutations, though a few inherited cases have been reported. The disorder itself is not usually fatal, but some associated medical issues, such as seizures or feeding difficulties, can be serious if untreated.

Signs and Symptoms

Common symptoms include:

  • Global developmental delay and intellectual disability (almost all cases)
  • Speech delay (different levels, some patients being completely non-verbal)
  • Motor impairments
  • Behavioral issues
  • Abnormal MRI
  • Autism spectrum disorder
  • Epilepsy
  • Distinct facial features
  • Short stature, small hands and feet
  • Low muscle tone (hypotonia), sleep problems, scoliosis, and contractures
  • Gastrointestinal issues like reflux, constipation, or diarrhea.
  • Other less common symptoms include birth complications, congenital anomalies, or abnormal pain sensitivity.

Causes

Hao-Fountain syndrome is caused by variations in the USP7 gene, located on chromosome 16. in USP7 are either point mutations (meaning just one letter in the DNA code is changed) or gene deletions (when the entire gene is missing).

Most cases are de novo mutations, meaning they are not inherited from parents. In a few cases, the condition has been inherited in an autosomal dominant pattern, which means that someone who receives a single copy of an abnormal USP7 gene from either parent may have this disorder. For someone who has a USP7 mutation, their chance of passing it to their children is 50%.

Laboratory Investigations

Diagnosis takes place by genetic testing, such us whole-exome sequencing, to identify USP7 point mutations), or chromosome microarray analysis (CMA) for gene deletions.

Once diagnosed, the following tests are usually recommended:

Assessment

Assessment by a pediatric ophthalmologist.

Brain MRI

Taken after 40 months of age to assess for structural abnormalities.

Cognitive and Behavioral Testing

Formal cognitive and behavioral testing by a licensed pediatric psychiatrist.

Consultation

With a gastroenterologist for any reflux, vomiting, or chronic constipation/diarrhea issues.

EEG

To test for abnormal electric activity that could cause/predispose seizures.

Full assessment

Assessment by a speech pathologist, and for physical and occupational therapy.

IGF-1 and IGF-BP3 measurement

Measurement of IGF-1 and IGF-BP3 to screen for growth hormone deficiency.

Sleep study

Sleep apnea test/sleep study

Treatment and Therapies

There is no cure, but treatment is tailored to each person’s symptoms and may include:

  • Speech, occupational, and physical therapy to address developmental delays
  • Behavioral therapy for autism, ADHD, or challenging behaviors
  • Anti-seizure medications if epilepsy is present
  • Gastrointestinal management for reflux or constipation
  • Orthopedic care for movement issues or contractures
  • Nutritional support and feeding interventions for infants with feeding difficulties

A team of specialists is often needed, and genetic counseling is recommended for families. Most people require lifelong support. Early and ongoing intervention can greatly improve outcomes.

Outlook

With early intervention and supportive care, many individuals with Hao-Fountain syndrome can make progress in development and communication, though most will need lifelong assistance. Independence as adults is unlikely for most, but abilities vary widely. The disorder affects daily routines, school, and family life. Special education and therapies are important. Diet and exercise do not cure the disorder but can help with general health. Families may need to adjust routines and seek community resources for support.

Resources

Foundation for Hao Fountain Syndrome

Our mission is to cure Hao-Fountain Syndrome (USP7-related diseases). We do this by funding research and identifying more patients.

The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.

Research

Currently, there are no listings for “Hao-Fountain Syndrome” in ClinicalTrials.gov. Check back often and talk with your healthcare provider to identify upcoming trials.

If you have an interest in searching for any future trials that may be starting:

  1. Go to the Home page of ClinicalTrials.gov
  2. In the “Condition or disease” field, type “Disorder”. A drop-down list will appear if this disorder is included.
  3. You can narrow the search with the “Other terms”, “Intervention/Treatment”, and “Location” fields.
  4. Under “Study Status”, click on “Recruiting and not yet recruiting studies”.
  5. Click on “More Filters”, “Age”, “Child (birth – 17)”.

ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.

Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.

Find Clinical Trials For Hao-Fountain Syndrome

Family Stories

The Foundation for Hao-Fountain Syndrome shares stories of their warriors – individuals affected by a variation of the USP7 gene.

The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.

References
  1. National Organization for Rare Disorders. Hao-Fountain syndrome [Internet]. Danbury (CT): National Organization for Rare Disorders; 2023 Nov 20 [cited 2025 Jun 10]. Available from: https://rarediseases.org/mondo-disease/hao-fountain-syndrome/
  2. Hao-Fountain Syndrome (HAFOUS) [Internet]. Boston (MA): FDNA; 2024 Dec 2 [cited 2025 Jun 10]. Available from: https://fdna.com/health/resource-center/usp7-related-disorder/
  3. Wimmer MC, Brennenstuhl H, Hirsch S, Dötsch L, Unser S, Caro P, Schaaf CP. Hao-Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum. Clin Genet. 2024 May;105(5):499-509. doi:10.1111/cge.14480. PMID: 38221796.
  4. Hao-Fountain syndrome. Genetics Home Reference [Internet]. Bethesda (MD): National Institutes of Health; [cited 2025 Jun 10]. Available from: https://medlineplus.gov/genetics/
  5. Marbach F, Schaaf CP. Response to Briuglia et al. Genet Med. 2021; 23(2):423-424. doi:10.1038/s41436-020-00977-y
  6. Fountain MD, Schaaf CP. Prader-Willi syndrome and Schaaf-Yang syndrome: neurodevelopmental diseases intersecting at the MAGEL2 gene. Diseases. 2016;4(1):2. doi:10.3390/diseases4010002
  7. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10-26. doi:10.1038/gim.0b013e31822bead0
  8. McCarthy J, Lupo PJ, Kovar E, et al. Schaaf-Yang syndrome overview: report of 78 individuals. Am J Med Genet A. 2018;176(12):2564-2574. doi:10.1002/ajmg.a.40650
  9. Fragile X syndrome: a review of clinical and molecular diagnoses. Ciaccio C, Fontana L, Milani D, Tabano S, Miozzo M, Esposito S. Ital J Pediatr. 2017;43:39. doi: 10.1186/s13052-017-0355-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Itani KN, Elfaki S. A Rare Case of Hao-Fountain Syndrome Mimicking Fragile X Syndrome. Cureus. 2023 Sep 15;15(9):e45816. doi:10.7759/cureus.45816. PMID: 37849578; PMCID: PMC10577392.
  11. Holder JL Jr, Hamdan FF, Michaud JL. SYNGAP1-Related Intellectual Disability. 2019 Feb 21. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537721/
  12. Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai

This overview is for general information and is not a substitute for advice from your child's care team.

← Back to the Disorder Directory